These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
633 related articles for article (PubMed ID: 8795567)
1. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein. Quesada AR; García Grávalos MD; Fernández Puentes JL Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567 [TBL] [Abstract][Full Text] [Related]
2. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy. Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321 [TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative. Méndez-Vidal C; Quesada AR Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452 [TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Siegsmund MJ; Kreukler C; Steidler A; Nebe T; Köhrmann KU; Alken P Urol Res; 1997; 25(1):35-41. PubMed ID: 9079744 [TBL] [Abstract][Full Text] [Related]
5. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
6. Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agents. Quesada AR; Barbacid MM; Mira E; Aracil M; Márquez G Cancer Lett; 1996 Jan; 99(1):109-14. PubMed ID: 8564921 [TBL] [Abstract][Full Text] [Related]
7. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux. Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402 [TBL] [Abstract][Full Text] [Related]
8. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110 [TBL] [Abstract][Full Text] [Related]
9. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210 [TBL] [Abstract][Full Text] [Related]
10. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro. Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786 [TBL] [Abstract][Full Text] [Related]
12. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209 [TBL] [Abstract][Full Text] [Related]
13. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells. Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879 [TBL] [Abstract][Full Text] [Related]
14. Lamellarins as inhibitors of P-glycoprotein-mediated multidrug resistance in a human colon cancer cell line. Plisson F; Huang XC; Zhang H; Khalil Z; Capon RJ Chem Asian J; 2012 Jun; 7(7):1616-23. PubMed ID: 22473938 [TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative. Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579 [TBL] [Abstract][Full Text] [Related]
16. Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells. Chauvier D; Morjani H; Manfait M Breast Cancer Res Treat; 2002 May; 73(2):113-25. PubMed ID: 12088114 [TBL] [Abstract][Full Text] [Related]
18. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance. Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365 [TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
20. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells. Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]